Interleukin-1 alpha and high mobility group box-1 secretion in polyinosinic:polycytidylic-induced colorectal cancer cells occur via RIPK1-dependent mechanism and participate in tumourigenesis

Antonic V, Stojadinovic A, Kester KE, Weina PJ, Brücher BL, Protic M, Avital I, Izadjoo M (2013) Significance of infectious agents in colorectal cancer development. J Cancer 4:227–240 Berger SB, Kasparcova V, Hoffman S, Swift B, Dare L, Schaeffer M, Capriotti C, Cook M, Finger J, Hughes-Earle A, Harris PA, Kaiser WJ, Mocarski ES, Bertin J, Gough PJ (2014) Cutting edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice. J Immunol 192:5476–5480 Bobrovnikova-Marjon E, Grigoriadou C, Pytel D, Zhang F, Ye J, Koumenis C, Cavener D, Diehl JA (2010) PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene 29:3881–3895 Brouwer NPM, Bos ACRK, Lemmens VEPP, Tanis PJ, Hugen N, Nagtegaal ID, de Wilt JHW, Verhoeven RHA (2018) An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients. Int J Cancer 143:2758–2766 Buchrieser J, Oliva-Martin MJ, Moore MD, Long JCD, Cowley SA, Perez-Simón JA, James W, Venero JL (2018) RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation. Cell Death Dis 9:973 Cheng KJ, Alshawsh MA, Mejia Mohamed EH, Thavagnanam S, Sinniah A, Ibrahim ZA (2020) HMGB1: an overview of its versatile roles in the pathogenesis of colorectal cancer. Cell Oncol (dordr) 43:177–193 Cheng KJ, Mejia Mohammed EH, Khong TL, Mohd Zain S, Thavagnanam S, Ibrahim ZA (2021) IL-1α and colorectal cancer pathogenesis: enthralling candidate for anti-cancer therapy. Crit Rev Oncol Hematol 163:103398 Chiu JW, Binte Hanafi Z, Chew LCY, Mei Y, Liu H (2021) IL-1α processing, signaling and its role in cancer progression. Cells 10:92 Choi J-A, Song C-H (2020) Insights into the role of endoplasmic reticulum stress in infectious diseases. Front Immunol. https://doi.org/10.3389/fimmu.2019.03147 Collett GP, Redman CW, Sargent IL, Vatish M (2018) Endoplasmic reticulum stress stimulates the release of extracellular vesicles carrying danger-associated molecular pattern (DAMP) molecules. Oncotarget 9:6707–6717 Corazzari M, Gagliardi M, Fimia GM, Piacentini M (2017) Endoplasmic reticulum stress unfolded protein response, and cancer cell fate. Front Oncol. https://doi.org/10.3389/fonc.2017.00078 Di Paolo NC, Shayakhmetov DM (2016) Interleukin 1α and the inflammatory process. Nat Immunol 17:906–913 Di Maggio S, Milano G, De Marchis F, D’Ambrosio A, Bertolotti M, Palacios BS, Badi I, Sommariva E, Pompilio G, Capogrossi MC, Raucci A (2017) Non-oxidizable HMGB1 induces cardiac fibroblasts migration via CXCR4 in a CXCL12-independent manner and worsens tissue remodeling after myocardial infarction. Biochim Biophys Acta (BBA) Mol Basis Dis 1863:2693–2704 Dillon CP, Weinlich R, Rodriguez DA, Cripps JG, Quarato G, Gurung P, Verbist KC, Brewer TL, Llambi F, Gong Y-N, Janke LJ, Kelliher MA, Kanneganti T-D, Green DR (2014) RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157:1189–1202 Estornes Y, Aguileta MA, Dubuisson C, De Keyser J, Goossens V, Kersse K, Samali A, Vandenabeele P, Bertrand MJM (2014) RIPK1 promotes death receptor-independent caspase-8-mediated apoptosis under unresolved ER stress conditions. Cell Death Dis 5:e1555–e1555 Fan H, Jiang C, Zhong B, Sheng J, Chen T, Chen Q, Li J, Zhao H (2018) Matrine ameliorates colorectal cancer in rats via inhibition of HMGB1 signaling and downregulation of IL-6, TNF-α, and HMGB1. J Immunol Res 2018:5408324 Fernandes-Alnemri T, Wu J, Yu JW, Datta P, Miller B, Jankowski W, Rosenberg S, Zhang J, Alnemri ES (2007) The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ 14:1590–1604 Gelfo V, Mazzeschi M, Grilli G, Lindzen M, Santi S, D’Uva G, Győrffy B, Ardizzoni A, Yarden Y, Lauriola M (2018) A novel role for the interleukin-1 receptor axis in resistance to anti-EGFR therapy. Cancers (basel) 10:355 Geng J, Ito Y, Shi L, Amin P, Chu J, Ouchida AT, Mookhtiar AK, Zhao H, Xu D, Shan B, Najafov A, Gao G, Akira S, Yuan J (2017) Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat Commun 8:359 Greten FR, Grivennikov SI (2019) Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51:27–41 Günther C, Ruder B, Stolzer I, Dorner H, He GW, Chiriac MT, Aden K, Strigli A, Bittel M, Zeissig S, Rosenstiel P, Atreya R, Neurath MF, Wirtz S, Becker C (2019) Interferon lambda promotes paneth cell death via STAT1 signaling in mice and is increased in inflamed ileal tissues of patients with Crohn’s disease. Gastroenterology 157:1310-1322.e13 Ha TK, Hansen AH, Kildegaard HF, Lee GM (2019) BiP inducer X: An ER stress inhibitor for enhancing recombinant antibody production in CHO cell culture. Biotechnol J 14:e1900130 Hanahan D, Weinberg Robert A (2011) Hallmarks of cancer: the next generation. Cell 144:646–674 Hillenbrand A, Fassler J, Huber N, Xu P, Henne-Bruns D, Templin M, Schrezenmeier H, Wolf AM, Knippschild U (2012) Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls. BMC Cancer 12:545 Hreggvidsdottir HS, Ostberg T, Wähämaa H, Schierbeck H, Aveberger AC, Klevenvall L, Palmblad K, Ottosson L, Andersson U, Harris HE (2009) The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation. J Leukoc Biol 86:655–662 Hreggvidsdóttir HS, Lundberg AM, Aveberger A-C, Klevenvall L, Andersson U, Harris HE (2012) High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor. Mol Med 18:224–230 Hu C-L, Zhang Y-J, Zhang X-F, Fei X, Zhang H, Li C-G, Sun B (2021) 3D culture of circulating tumor cells for evaluating early recurrence and metastasis in patients with hepatocellular carcinoma. Onco Targets Ther 14:2673–2688 Huang W, Zhao H, Dong H, Wu Y, Yao L, Zou F, Cai S (2016) High-mobility group box 1 impairs airway epithelial barrier function through the activation of the RAGE/ERK pathway. Int J Mol Med 37:1189–1198 Huang Y, Yang W, Zeng H, Hu C, Zhang Y, Ding N, Fan G, Shao L, Kuang B (2018) Droxinostat sensitizes human colon cancer cells to apoptotic cell death via induction of oxidative stress. Cell Mol Biol Lett 23:34–34 Ishaq M, Natarajan V (2016) Integrated stress response signaling pathways induced by supraphysiological concentrations of thyroid hormone inhibit viral replication. Signal Transduct Insights. https://doi.org/10.4137/STI.S39844 Jurida L, Soelch J, Bartkuhn M, Handschick K, Müller H, Newel D, Weber A, Dittrich-Breiholz O, Schneider H, Bhuju S, Saul Vera V, Schmitz ML, Kracht M (2015) The activation of IL-1-induced enhancers depends on TAK1 kinase activity and NF-κB p65. Cell Rep 10:726–739 Kandel-Kfir M, Almog T, Shaish A, Shlomai G, Anafi L, Avivi C, Barshack I, Grosskopf I, Harats D, Kamari Y (2015) Interleukin-1α deficiency attenuates endoplasmic reticulum stress-induced liver damage and CHOP expression in mice. J Hepatol 63:926–933 Kanwar SS, Yu Y, Nautiyal J, Patel BB, Majumdar APN (2010) The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres. Mol Cancer 9:212–212 Kearney CJ, Cullen SP, Clancy D, Martin SJ (2014) RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis. FEBS J 281:4921–4934 Kimata Y, Oikawa D, Shimizu Y, Ishiwata-Kimata Y, Kohno K (2004) A role for BiP as an adjustor for the endoplasmic reticulum stress-sensing protein Ire1. J Cell Biol 167:445–456 Kudo T, Kanemoto S, Hara H, Morimoto N, Morihara T, Kimura R, Tabira T, Imaizumi K, Takeda M (2008) A molecular chaperone inducer protects neurons from ER stress. Cell Death Differ 15:364–375 le Rolle A-F, Chiu TK, Fara M, Shia J, Zeng Z, Weiser MR, Paty PB, Chiu VK (2015) The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts. J Transl Med 13:199 Lee H, Song M, Shin N, Shin CH, Min BS, Kim HS, Yoo JS, Kim H (2012) Diagnostic significance of serum HMGB1 in colorectal carcinomas. PLoS ONE 7:e34318 Lenna S, Chrobak I, Farina GA, Rodriguez-Pascual F, Lamas S, Lafyatis R, Scorza R, Trojanowska M (2013) HLA-B35 and dsRNA induce endothelin-1 via activation of ATF4 in human microvascular endothelial cells. PLoS ONE 8:e56123 Lin CW, Liao MY, Lin WW, Wang YP, Lu TY, Wu HC (2012) Epithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer. J Biol Chem 287:39449–39459 Liu ZY, Wu B, Guo YS, Zhou YH, Fu ZG, Xu BQ, Li JH, Jing L, Jiang JL, Tang J, Chen ZN (2015) Necrostatin-1 reduces intestinal inflammation and colitis-associated tumorigenesis in mice. Am J Cancer Res 5:3174–3185 Liu Q, Zhang H, Jiang X, Qian C, Liu Z, Luo D (2017) Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis. Mol Cancer 16:176–176 Liu W, Zhang D, Luo M, Jia F, Peng L, Li X, Xia Y (2021) TNF-like weak inducer of apoptosis promotes angiogenesis, thereby exacerbating cutaneous psoriatic disease. J Investig Dermatol 141:1356-1360.e8 Łukaszewicz-Zając M, Pączek S, Mroczko P, Kulczyńska-Przybik A (2020) The significance of CXCL1 and CXCL8 as well as their specific receptors in colorectal cancer. Cancer Manag Res 12:8435–8443 Lukens JR, Vogel P, Johnson GR, Kelliher MA, Iwakura Y, Lamkanfi M, Kanneganti T-D (2013) RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3. Nature 498:224–227 Malik A, Sharma D, Zhu Q, Karki R, Guy CS, Vogel P, Kanneganti T-D (2016) IL-33 regulates the IgA-microbiota axis to restrain IL-1α-dependent colitis and tumorigenesis. J Clin Invest 126:4469–4481 Matsuo Y, Sawai H, Ma J, Xu D, Ochi N, Yasuda A, Takahashi H, Funahashi H, Takeyama H (2009) IL-1alpha secreted by colon cancer cells enhances angiogenesis: the relationship between IL-1alpha release and tumor cells’ potential for liver metastasis. J Surg Oncol 99:361–367 Moriwaki K, Bertin J, Gough PJ, Orlowski GM, Chan FK (2015) Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death. Cell Death Dis 6:e1636–e1636 Murao A, Aziz M, Wang H, Brenner M, Wang P (2021) Release mechanisms of major DAMPs. Apoptosis 26:152–162 Newton K (2015) RIPK1 and RIPK3: critical regulators of inflammation and cell death. Trends Cell Biol 25:347–353 Nie X, Xia F, Liu Y, Zhou Y, Ye W, Hean P, Meng J, Liu H, Liu L, Wen J, Ren X, Chen W-D, Wang Y-D (2019) Downregulation of Wnt3 suppresses colorectal cancer development through inhibiting cell proliferation and migration. Front Pharmacol. https://doi.org/10.3389/fphar.2019.01110 Ning Y, Manegold PC, Hong YK, Zhang W, Pohl A, Lurje G, Winder T, Yang D, LaBonte MJ, Wilson PM, Ladner RD, Lenz H-J (2011) Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int J Cancer 128:2038–2049 Park IA, Heo S-H, Song IH, Kim Y-A, Park HS, Bang WS, Park SY, Jo J-H, Lee HJ, Gong G (2016) Endoplasmic reticulum stress induces secretion of high-mobility group proteins and is associated with tumor-infiltrating lymphocytes in triple-negative breast cancer. Oncotarget 7:59957–59964 Powan P, Luanpitpong S, He X, Rojanasakul Y, Chanvorachote P (2017) Detachment-induced E-cadherin expression promotes 3D tumor spheroid formation but inhibits tumor formation and metastasis of lung cancer cells. Am J Physiol Cell Physiol 313:C556–C566 Reithmeier A, Panizza E, Krumpel M, Orre LM, Branca RMM, Lehtiö J, Ek-Rylander B, Andersson G (2017) Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells. BMC Cancer 17:650–650 Sanjana NE, Shalem O, Zhang F (2014) Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods 11:783–784 Saveljeva S, Mc Laughlin SL, Vandenabeele P, Samali A, Bertrand MJM (2015) Endoplasmic reticulum stress induces ligand-independent TNFR1-mediated necroptosis in L929 cells. Cell Death Dis 6:e1587–e1587 Schmitt M, Greten FR (2021) The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol 21:653–667 Simpson J, Loh Z, Ullah MA, Lynch JP, Werder RB, Collinson N, Zhang V, Dondelinger Y, Bertrand MJM, Everard ML, Blyth CC, Hartel G, Van Oosterhout AJ, Gough PJ, Bertin J, Upham JW, Spann KM, Phipps S (2020) Respiratory syncytial virus infection promotes necroptosis and HMGB1 release by airway epithelial cells. Am J Respir Crit Care Med 201:1358–1371 Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MRM, Yagita H (2003) Nature’s TRAIL—on a path to cancer immunotherapy. Immunity 18:1–6 Soto-Díaz K, Juda MB, Blackmore S, Walsh C, Steelman AJ (2020) TAK1 inhibition in mouse astrocyte cultures ameliorates cytokine-induced chemokine production and neutrophil migration. J Neurochem 152:697–709 Suda J, Dara L, Yang L, Aghajan M, Song Y, Kaplowitz N, Liu ZX (2016) Knockdown of RIPK1 markedly exacerbates murine immune-mediated liver injury through massive apoptosis of hepatocytes, independent of necroptosis and inhibition of NF-κB. J Immunol 197:3120–3129 Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249 Syafruddin SE, Rodrigues P, Vojtasova E, Patel SA, Zaini MN, Burge J, Warren AY, Stewart GD, Eisen T, Bihary D, Samarajiwa SA, Vanharanta S (2019) A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma. Nat Commun 10:1152 Tao L, Lin H, Wen J, Sun Q, Gao Y, Xu X, Wang J, Zhang J, Weng D (2018) The kinase receptor-interacting protein 1 is required for inflammasome activation induced by endoplasmic reticulum stress. Cell Death Dis 9:641–641 Tripathi A, Shrinet K, Kumar A (2019) HMGB1 protein as a novel target for cancer. Toxicol Rep 6:253–261 Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, De Marchis F, Liu J, Antonelli A, Preti A, Raeli L, Shams SS, Yang H, Varani L, Andersson U, Tracey KJ, Bachi A, Uguccioni M, Bianchi ME (2012) Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 209:1519–1528 Wähämaa H, Schierbeck H, Hreggvidsdottir HS, Palmblad K, Aveberger AC, Andersson U, Harris HE (2011) High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts. Arthritis Res Ther 13:R136 Wang X, Jiang W, Yan Y, Gong T, Han J, Tian Z, Zhou R (2014) RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway. Nat Immunol 15:1126–1133 Wang H, Wang Y, Du Q, Lu P, Fan H, Lu J, Hu R (2016) Inflammasome-independent NLRP3 is required for epithelial-mesenchymal transition in colon cancer cells. Exp Cell Res 342:184–192 Wang R, Wu W, Li W, Huang S, Li Z, Liu R, Shan Z, Zhang C, Li W, Wang S (2018) Activation of NLRP3 inflammasome promotes foam cell formation in vascular smooth muscle cells and atherogenesis via HMGB1. J Am Heart Assoc 7:e008596 Wang C-Q, Huang B-F, Wang Y, Tang C-H, Jin H-C, Shao F, Shao J-K, Wang Q, Zeng Y (2020) Subcellular localization of HMGB1 in colorectal cancer impacts on tumor grade and survival prognosis. Sci Rep 10:18587 Yang H, Lundbäck P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, Al-Abed Y, Andersson U, Tracey KJ (2021) Redox modifications of cysteine residues regulate the cytokine activity of HMGB1. Mol Med 27:58 Zhang K, Liu H, Song Z, Jiang Y, Kim H, Samavati L, Nguyen HM, Yang Z-Q (2020) The UPR transducer IRE1 promotes breast cancer malignancy by degrading tumor suppressor microRNAs. iScience. https://doi.org/10.1016/j.isci.2020.101503 Zhao J, Ou B, Han D, Wang P, Zong Y, Zhu C, Liu D, Zheng M, Sun J, Feng H, Lu A (2017) Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways. Mol Cancer 16:70